Skip to main content

Squarepoint Ops LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1642575 NEW YORK, NY

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,177,023
+$11,537,916 QoQ
Shares Held
1,590,736
+159.1% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 242 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2026
CallValue
$3,509,913
CallShares
240,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. SMMT ranks #11 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,509,913 240,900
2026-06-30 $23,177,023 1,590,736
2026-03-31 $11,639,107 613,877
2025-12-31 $12,512,520 715,410
2025-09-30 $2,464,738 119,300
2025-09-30 $16,154,054 781,900
2025-09-30 $2,269,005 109,826
2025-06-30 $18,507,216 869,700
2025-06-30 $6,197,204 291,222
2025-06-30 $8,863,120 416,500
2025-03-31 $416,664 21,600
2025-03-31 $424,380 22,000
2024-12-31 $1,532,885 85,900
2024-12-31 $645,989 36,200
2024-12-31 $327,402 18,347
2024-06-30 $671,299 86,064
2024-03-31 $121,923 29,450
2023-03-31 $499,761 285,578
2020-12-31 $59,929 12,751